{"id":16185,"date":"2026-03-11T09:00:00","date_gmt":"2026-03-11T12:00:00","guid":{"rendered":"https:\/\/www.biolabfarma.com.br\/?post_type=imprensa&p=16185"},"modified":"2026-03-11T09:13:01","modified_gmt":"2026-03-11T12:13:01","slug":"after-surpassing-2025-targets-biolab-farmaceutica-accelerates-growth-strategy-for-2026","status":"publish","type":"imprensa","link":"https:\/\/www.biolabeco.com.br\/en\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/","title":{"rendered":"After exceeding 2025 targets, Biolab Farmac\u00eautica accelerates growth strategy for 2026"},"content":{"rendered":"

With an investment of 10% of turnover in RD&I, the pharmaceutical company is betting on predictive AI, silver economy and technological exchange with Canada to boost global expansion<\/strong><\/em><\/h4>\n\n\n\n

The pharmaceutical market is undergoing a strategic transformation in which innovation, corporate governance and technology are taking center stage. In the most recent episode of Biolab Cast<\/strong>, a Biolab Farmac\u00eautica - one of the ten largest pharmaceutical companies in Brazil -<\/strong> brought together experts in technology and innovation to discuss how the company exceeded its 2025 targets and what strategies are shaping its growth for 2026.<\/p>\n\n\n\n

Mediated by journalist Daiana Garbin<\/strong>, CEO of Biolab, Fabio Amorosino<\/strong>, received two members of the company's advisory board: Jo\u00e3o Bezerra Leite<\/strong>, former CTO of Ita\u00fa, and Paulo Gandolfi<\/strong>, President of 3M Brazil.<\/p>\n\n\n\n

During the conversation, the executives emphasized that the company's results are directly linked to a model of governance that combines strategic rigor and agile decision-making<\/strong>, allowing the pharmaceutical company to transform global trends into health solutions for patients.<\/p>\n\n\n\n

Governance and growth strategy<\/h2>\n\n\n\n

Fabio Amorosino took over as CEO after participating in the company's first Advisory Board, a phase in which the governance structure began to be consolidated. His transition to executive leadership took place gradually, with the accompaniment and experience of the partners Cleiton de Castro Marques, Paulo de Castro Marques and Dr. Dante Alario J\u00fanior<\/strong>.<\/p>\n\n\n\n

Now, the company is experiencing a new institutional moment with the integration of founders, independent directors and the second generation of shareholders<\/strong>, This move marks a stage of maturity in the company's corporate management. According to Amorosino, this combination of experience and renewal helps to keep the company competitive in an increasingly dynamic global scenario.<\/p>\n\n\n\n

Technology and Pharma 4.0 drive innovation<\/h2>\n\n\n\n

Biolab Farmac\u00eautica's strategy also involves robust investment in Research, Development and Innovation (RD&I), which today accounts for 10% of the company's turnover. The company is intensifying its journey towards Pharma 4.0, with the use of predictive artificial intelligence, factory automation and process digitalization, as well as strengthening its international presence with Canada as a gateway to new markets.<\/p>\n\n\n\n

For Jo\u00e3o Bezerra Leite, digital transformation in the pharmaceutical sector requires more than simply digitizing old processes. \u201cDigital transformation is not about digitizing old processes. It's about rethinking the way we work, taking advantage of technology to evolve and do things differently, and not just innovating for the sake of aesthetics,\u201d he says.<\/p>\n\n\n\n

The internationalization strategy is also gaining momentum with the arrival of Adriano Treve on the Advisory Board, broadening the company's view of the global healthcare ecosystem. Paulo Gandolfi emphasizes that this expansion goes beyond commercial presence. \u201cIt's not just about exports. It's an exchange of intelligence. We transfer technologies from there to here and from here to there, learning from the best in each market,\u201d he explains.<\/p>\n\n\n\n

Silver economy and longevity at the heart of the strategy<\/h2>\n\n\n\n

Another relevant theme of the episode was the so-called silver economy<\/strong>, This concept brings together opportunities related to an ageing population and longevity.<\/p>\n\n\n\n

At Biolab, this trend is incorporated into both product development and people management. One example is the \u201c3 in 1\u201d pill for hypertension, which simplifies treatment and improves patient compliance.<\/p>\n\n\n\n

At the same time, the company seeks to value professionals over the age of 50 within its corporate structure.<\/p>\n\n\n\n

\n

\u201cThe focus is on putting together a puzzle in which different generations complement each other,\u201d said Jo\u00e3o Bezerra Leite.<\/p>\n<\/blockquote>\n\n\n\n

According to him, longevity is no longer just a demographic statistic and has become a strategic pillar of branding and innovation in the health sector<\/strong>.<\/p>\n\n\n\n

New innovation cycle for 2026<\/h2>\n\n\n\n

At the end of the conversation, Fabio Amorosino said that meeting the 2025 targets had created a new operational mentality within the company.<\/p>\n\n\n\n

The Biolab Pharmaceuticals for 2026<\/strong> is to maintain a continuous cycle of growth and innovation.<\/p>\n\n\n\n

\n

\u201cWe want to maintain a natural spiral of growth, in which each achievement becomes the starting point for the next innovation,\u201d he concluded.<\/p>\n<\/blockquote>\n\n\n\n

The full episode of Biolab Cast<\/strong> is available on the main audio platforms and also on YouTube.<\/p>\n\n\n\n

Watch:
https:\/\/www.youtube.com\/watch?v=YzRhdD6x0IU<\/a><\/p>\n\n\n\n

Check out the full article here: After exceeding 2025 targets, Biolab Farmac\u00eautica accelerates growth strategy for 2026<\/a><\/p>","protected":false},"featured_media":14275,"template":"","categories":[1577],"acf":[],"yoast_head":"\nAp\u00f3s superar metas de 2025, Biolab Farmac\u00eautica acelera estrat\u00e9gia de crescimento para 2026 - Biolab & Co<\/title>\n<meta name=\"description\" content=\"O mercado farmac\u00eautico vive uma transforma\u00e7\u00e3o impulsionada por inova\u00e7\u00e3o. No Biolab Cast, a Biolab Farmac\u00eautica, discute esse novo cen\u00e1rio.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biolabeco.com.br\/en\/press\/after-surpassing-2025-targets-biolab-farmaceutica-accelerates-growth-strategy-for-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ap\u00f3s superar metas de 2025, Biolab Farmac\u00eautica acelera estrat\u00e9gia de crescimento para 2026\" \/>\n<meta property=\"og:description\" content=\"O mercado farmac\u00eautico vive uma transforma\u00e7\u00e3o impulsionada por inova\u00e7\u00e3o. No Biolab Cast, a Biolab Farmac\u00eautica, discute esse novo cen\u00e1rio.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biolabeco.com.br\/en\/press\/after-surpassing-2025-targets-biolab-farmaceutica-accelerates-growth-strategy-for-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Biolab & Co\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-11T12:13:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2025\/08\/Biolab_Planta_PousoAlegre-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1917\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/\",\"url\":\"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/\",\"name\":\"Ap\u00f3s superar metas de 2025, Biolab Farmac\u00eautica acelera estrat\u00e9gia de crescimento para 2026 - Biolab & Co\",\"isPartOf\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2025\/08\/Biolab_Planta_PousoAlegre-scaled.jpg\",\"datePublished\":\"2026-03-11T12:00:00+00:00\",\"dateModified\":\"2026-03-11T12:13:01+00:00\",\"description\":\"O mercado farmac\u00eautico vive uma transforma\u00e7\u00e3o impulsionada por inova\u00e7\u00e3o. No Biolab Cast, a Biolab Farmac\u00eautica, discute esse novo cen\u00e1rio.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#primaryimage\",\"url\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2025\/08\/Biolab_Planta_PousoAlegre-scaled.jpg\",\"contentUrl\":\"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2025\/08\/Biolab_Planta_PousoAlegre-scaled.jpg\",\"width\":2560,\"height\":1917},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biolabeco.com.br\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ap\u00f3s superar metas de 2025, Biolab Farmac\u00eautica acelera estrat\u00e9gia de crescimento para 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biolabeco.com.br\/#website\",\"url\":\"https:\/\/www.biolabeco.com.br\/\",\"name\":\"Biolab\",\"description\":\"Na Biolab & Co, ci\u00eancia e cuidado caminham juntos. Saiba como promovemos sa\u00fade com responsabilidade socioambiental e tecnologia.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biolabeco.com.br\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"After exceeding 2025 targets, Biolab Farmac\u00eautica accelerates growth strategy for 2026 - Biolab & Co","description":"The pharmaceutical market is undergoing a transformation driven by innovation. In Biolab Cast, Biolab Farmac\u00eautica discusses this new scenario.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biolabeco.com.br\/en\/press\/after-surpassing-2025-targets-biolab-farmaceutica-accelerates-growth-strategy-for-2026\/","og_locale":"en_US","og_type":"article","og_title":"Ap\u00f3s superar metas de 2025, Biolab Farmac\u00eautica acelera estrat\u00e9gia de crescimento para 2026","og_description":"O mercado farmac\u00eautico vive uma transforma\u00e7\u00e3o impulsionada por inova\u00e7\u00e3o. No Biolab Cast, a Biolab Farmac\u00eautica, discute esse novo cen\u00e1rio.","og_url":"https:\/\/www.biolabeco.com.br\/en\/press\/after-surpassing-2025-targets-biolab-farmaceutica-accelerates-growth-strategy-for-2026\/","og_site_name":"Biolab & Co","article_modified_time":"2026-03-11T12:13:01+00:00","og_image":[{"width":2560,"height":1917,"url":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2025\/08\/Biolab_Planta_PousoAlegre-scaled.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/","url":"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/","name":"After exceeding 2025 targets, Biolab Farmac\u00eautica accelerates growth strategy for 2026 - Biolab & Co","isPartOf":{"@id":"https:\/\/www.biolabeco.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2025\/08\/Biolab_Planta_PousoAlegre-scaled.jpg","datePublished":"2026-03-11T12:00:00+00:00","dateModified":"2026-03-11T12:13:01+00:00","description":"The pharmaceutical market is undergoing a transformation driven by innovation. In Biolab Cast, Biolab Farmac\u00eautica discusses this new scenario.","breadcrumb":{"@id":"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#primaryimage","url":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2025\/08\/Biolab_Planta_PousoAlegre-scaled.jpg","contentUrl":"https:\/\/www.biolabeco.com.br\/wp-content\/uploads\/2025\/08\/Biolab_Planta_PousoAlegre-scaled.jpg","width":2560,"height":1917},{"@type":"BreadcrumbList","@id":"https:\/\/www.biolabeco.com.br\/imprensa\/apos-superar-metas-de-2025-biolab-farmaceutica-acelera-estrategia-de-crescimento-para-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biolabeco.com.br\/"},{"@type":"ListItem","position":2,"name":"Ap\u00f3s superar metas de 2025, Biolab Farmac\u00eautica acelera estrat\u00e9gia de crescimento para 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.biolabeco.com.br\/#website","url":"https:\/\/www.biolabeco.com.br\/","name":"Biolab","description":"At Biolab & Co, science and care go hand in hand. Find out how we promote health with social and environmental responsibility and technology.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biolabeco.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/16185"}],"collection":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa"}],"about":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/types\/imprensa"}],"version-history":[{"count":1,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/16185\/revisions"}],"predecessor-version":[{"id":16186,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/imprensa\/16185\/revisions\/16186"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/media\/14275"}],"wp:attachment":[{"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/media?parent=16185"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.biolabeco.com.br\/en\/wp-json\/wp\/v2\/categories?post=16185"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}